BioCryst Pharmaceuticals-BioCryst scraps internal drug discovery programs, leans on partnerships to cut costs

BioCryst scraps internal drug discovery programs, leans on partnerships to cut costs

公司战略调整 - BioCryst Pharmaceuticals宣布将逐步结束其内部药物发现项目 [1] - 公司计划在2026年底前关闭其位于阿拉巴马州的研究设施 [1] - 公司战略转向外部合作以推动其管线发展 [1]

BioCryst Pharmaceuticals-BioCryst scraps internal drug discovery programs, leans on partnerships to cut costs - Reportify